Singapore Paincare's (SGX:FRQ) attributable profit for the six months ended Dec. 31, 2024, declined 53% to SG$453,000 from SG$969,000 a year earlier, according to a Friday filing with the Singapore Exchange.
Earnings per share dropped to SG$0.0026 compared with SG$0.0057 in the comparable period.
Revenue was up 2.8% year over year to SG$13.7 million from SG$13.4 million, driven by increased revenue from specialist clinics.
Shares of the health and medical treatment company were down over 3% in recent trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。